News - MedTech

New CEO and funding for ‘on-farm’ disease detection startup

Biotangents, a Scottish BioTech business, has secured £2.2 million of new funding. The funding w...

AI imaging to help treat Crohn’s Disease in UK hospitals

Motilent, a company specialising in the assessment of digestive diseases using AI medical image anal...

£1m funding for drug formulation company

A UK company which has developed a novel dry powder coating technology that opens up new possibiliti...

In Crypto: ‘If this is your first cryptowinter, then welcome’

The founder of Cardano - also a co-founder of Ethereum - has ‘welcomed’ new cryptocurrency inves...

£1m for ‘life-saving’ cancer care management device

A cancer care management device which aims to protect patients from a potentially lethal side effect...

Oxford spinout raises £75m to find medicines for rare diseases

An Oxford University spinout has raised £75.5 million to progress its drug pipeline in immunology a...

Careology founder: My wife’s cancer showed need to give patients control

There are few experiences in life more daunting than facing a cancer diagnosis. Alongside the dev...

Sensor tech ‘detects booze & drugs by scanning skin’

A Durham company which has developed sensor technology that can detect alcohol and drugs in a person...

MedTech 50 star GripAble raises £8.5m for global growth

GripAble, a London-based digital healthcare start-up delivering rehabilitation programmes to people ...

Pfizer in £400m swoop for UK respiratory virus MedTech

A respiratory virus MedTech based in Stevenage is to be acquired by pharmaceutical giant Pfizer in a...

MedTech Axol Bioscience raises £3.2m

Life science discovery provider Axol Bioscience has raised £3.2 million funding. The funding wil...

Struggling Sensyne Health replaces founder with new CEO

The founder and CEO of Sensyne Health plc is to leave the Oxford company.  Labour peer Lord Dray...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.